SBIR/STTR Research Award

Engineering of membrane protein chemosensors for therapeutic research

Award identifier 491b473edf4628eb03c78b2f6fe40baa8972d66499bc8543b2630a52adacd0c5Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$1,213,215

Program and phase

SBIR · Phase II

Award year

2014

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
INTEGRAL MOLECULAR INC
Proposal award date
2013-12-01
Contract end date
2018-05-31
UEI
DY9KSWE8EJB8
Solicitation number
PA11-134
Topic code
NIDCD

Research abstract

DESCRIPTION provided by applicant Cells require the ability to detect and respond to stimuli in their surroundings including to endogenous metabolites exogenous nutrients and environmental irritants The proteins that are responsible for this process are called chemosensors and are involved in regulating diverse biological processes involved in pain sensation dietary preference and metabolic control Because chemosensors transmit external environmental information into the cell nearly all chemosensors are structurally complex membrane proteins that span the cellandapos s plasma membrane multiple times such as ion channels transporters and G protein coupled receptors However because most chemosensors are difficult to express purify and solubilize structural and functional information about them has been exceptionally difficult to obtain The goal of this Phase proposal is to engineer chemosensors with increased surface expression and increased stability in solution and to map ligand and drug binding sites on these chemosensors PUBLIC HEALTH RELEVANCE This project will contribute to human health by providing tools that will enable new small molecules and therapeutic MAbs to be developed against specific chemosensor targets These targets are involved in the transmission of pain cancer and metabolic disorders yet there are currently no FDA approved drugs against any of our target protein families The lack of therapeutic drugs and antibodies against these targets and most chemosensors in general reflects their conformational complexity and the lack of tools that have been able to manipulate and engineer these proteins for commercial purposes

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

48 SBIR/STTR records share this UEI (2002–2025). Reported award amounts total $32,839,788. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.